hexamer
coiledcoil
form
ctermin
ntermin
heptad
repeat
chr
nhr
region
class
viral
fusion
protein
play
import
role
mediat
fusion
viral
cellular
membran
provid
clear
start
point
molecular
mimicri
drive
viral
fusion
inhibitor
design
unfortun
peptid
mimicri
short
region
chr
middl
east
respiratori
syndrom
coronaviru
merscov
spike
protein
thwart
loss
peptid
nativ
conform
taken
parent
protein
structur
describ
appropri
allhydrocarbon
stapl
short
helic
portionbas
peptid
reinforc
bioactiv
secondari
structur
remark
improv
antivir
potenc
result
stapl
peptid
could
effect
inhibit
infect
merscov
pseudoviru
spike
proteinmedi
fusion
addit
exhibit
improv
pharmacokinet
properti
suggest
strong
potenti
develop
antimerscov
therapeut
class
viral
fusion
protein
corona
retro
filo
orthomyxo
paramyxovirus
share
similar
appar
use
trimer
hairpin
sixhelix
bundl
mediat
membran
fusion
process
viru
target
cell
viral
fusion
apparatu
ctermin
heptad
repeat
chr
segment
trimer
viru
glycoprotein
zip
three
along
conserv
hydrophob
groov
peripheri
intern
threestrand
coil
coil
form
ntermin
heptad
repeat
nhr
region
fusion
protein
despit
topolog
similar
conform
fusionpromot
hexamer
helic
scaffold
portion
chr
domain
display
dramat
differ
length
exampl
fusion
core
structur
hiv
retrovirida
famili
member
contain
regular
chr
domain
involv
approxim
helic
turn
bind
central
trimer
nhr
helic
contrast
class
envelop
virus
includ
middl
east
respiratori
syndrom
coronaviru
merscov
coronavirida
famili
encod
notabl
dimorph
length
nhr
chr
helic
merscov
assembl
nhr
trimer
helic
turn
wherea
central
chr
helic
limit
turn
within
longer
heptadrepeat
sequenc
figur
block
nhrchr
interact
use
chrderiv
peptid
target
transient
expos
nhr
coil
coil
promis
approach
inhibit
membran
fusion
viral
infect
strategi
famili
decoy
structur
mimick
lengthi
ctermin
helic
hiv
identifi
lownanomolar
inhibitor
viral
entri
disappoint
synthet
peptid
span
region
merscov
chr
domain
sequenc
show
antimerscov
activ
although
typic
region
import
recognit
motif
merscov
fusion
core
format
short
chr
peptid
alon
retain
nativ
conform
owe
lack
structur
reinforc
provid
parent
protein
turn
retard
bind
partner
nhr
helic
peptid
stapl
base
differ
macrocycl
chemistri
key
techniqu
constrain
short
peptid
structur
therebi
preorgan
bound
conform
modul
helixmedi
interact
reduc
entrop
penalti
among
numer
stapl
chemistri
rutheniumcatalyz
rcm
one
noteworthi
method
method
produc
allhydrocarbonstapl
peptid
afford
high
level
induct
nucleat
thu
directli
result
peptid
targetbind
procliv
cell
permeabl
serum
stabil
furthermor
therapeut
potenti
stapl
peptid
showcas
grow
divers
biolog
set
two
hydrocarbonstapl
peptid
develop
aileron
therapeut
reach
clinic
trial
epitom
earli
indic
regard
clinic
translat
potenti
stabil
peptidomimet
present
studi
employ
hydrocarbon
stapl
recapitul
topographi
motif
found
merscov
chr
region
inhibit
merscov
infect
spike
proteinmedi
fusion
process
develop
stapl
peptid
perform
detail
studi
identifi
optim
stapl
site
effect
hydrophob
amino
acid
incorpor
gener
promis
therapeut
primari
structur
merscov
protein
hexamer
coiledcoil
fusion
complex
exhibit
heptad
repeat
pattern
usual
denot
structur
term
three
nhr
helic
form
trimer
coiledcoil
inner
core
use
residu
selfassoci
posit
particip
interhel
knobinhol
pack
interact
residu
posit
chr
helic
consid
critic
stabil
structur
figur
accord
crystal
structur
merscov
fusion
core
residu
posit
posit
chr
domain
adopt
canon
region
bind
deep
groov
nhr
trimer
semin
work
investig
stabil
coil
coil
suggest
helic
consist
fewer
three
heptad
gener
creat
enough
opportun
hydrophob
interact
core
favor
superhel
assembl
basi
xray
crystallographi
coiledcoil
sequencetostructur
relationship
studi
engin
peptid
contain
three
integr
heptad
design
span
residu
merscov
protein
chr
templat
inhibitor
design
figur
analysi
crystal
structur
chr
complex
nhr
helic
show
six
residu
posit
buri
addit
hydrophob
interact
contribut
side
chain
residu
form
four
hydrogen
bond
nhrhelic
trimer
residu
includ
via
mainchain
amino
oxygen
group
meanwhil
hydroxyl
group
side
chain
accept
hydrogen
bond
nh
group
nhr
helic
togeth
critic
hydrophob
stack
forc
hydrogen
bond
constitut
polar
contact
network
tightli
tie
chr
nhr
helix
initi
util
stapl
scan
approach
along
length
peptid
helix
away
critic
residu
identifi
optim
stapl
site
substitut
pair
alanin
abbrevi
residu
posit
wide
use
unnatur
amino
acid
type
stapl
accumul
evid
underlin
structur
stabil
coiledcoil
shown
superhelix
stabil
gener
articl
improv
insert
residu
hydrophob
side
chain
posit
among
six
buri
residu
leu
val
possess
high
hydropathi
indic
strongli
bind
groov
surfac
nhelix
trimer
fulli
hydrophob
side
chain
interact
met
tyr
polar
residu
basi
scan
studi
result
elect
creat
stapl
structur
hydrophob
mutat
buri
residu
individu
substitut
lnorleucin
isoster
met
analogu
less
polar
hydrophob
properti
f
respect
combin
replac
thu
expect
form
potenti
hydrophob
bind
core
effect
stapl
inhibit
merscov
proteinmedi
fusion
first
peptid
test
abil
inhibit
merscov
fusion
target
cell
use
previous
develop
merscov
proteinmedi
fusion
assay
shown
tabl
linear
wildtyp
exhibit
inhibit
concentr
peptid
cycliz
markedli
improv
inhibitori
activ
demonstr
among
mimet
strongli
inhibit
proteinmedi
fusion
ec
valu
respect
even
potent
activ
merscov
fusion
inhibitor
far
name
peptid
importantli
unmetathes
analogu
ie
peptid
contain
uncrosslink
residu
dramat
decreas
membran
fusion
inhibitori
potenc
tabl
result
reveal
critic
contribut
hydrocarbon
stapl
replic
local
topographi
merscov
short
ctermin
helic
therapeut
benefit
addit
shift
posit
allhydrocarbon
stapl
signific
effect
antimerscov
activ
peptid
stapl
respect
exhibit
similar
activ
compar
relev
unstapl
peptid
wherea
peptid
activ
compar
whose
crosslink
sconfigur
r
rconfigur
counterpart
provid
weaker
antimerscov
activ
consist
previou
public
reveal
requir
sform
build
block
stapl
type
final
explor
whether
incorpor
hydrophob
mutat
bind
interfac
could
lead
improv
biolog
activ
assay
replac
lnorleucin
ie
z
led
retain
high
activ
wherea
alon
combin
show
decreas
potenc
compar
indic
critic
role
hydrogen
bond
format
protein
nhr
trimer
although
buri
hydrophob
residu
may
contribut
energi
toward
stabil
coiledcoil
structur
polar
interact
subtl
specif
interact
network
requir
hydrocarbonstapl
peptid
stop
fusion
process
effici
peptid
acetyl
group
nterminu
carboxyamid
cterminu
b
asterisk
indic
posit
residu
react
form
allhydrocarbon
stapl
c
x
indic
posit
amino
acid
left
uncycl
denot
posit
amino
acid
react
form
stapl
e
ec
data
deriv
result
three
independ
experi
express
mean
standard
deviat
articl
stapl
peptid
inhibitor
pseudotyp
merscov
infect
subsequ
test
potenti
inhibitori
activ
peptid
exhibit
promis
inhibitori
potenc
fusion
assay
merscov
pseudoviru
infect
cell
shown
tabl
support
inform
figur
could
significantli
inhibit
merscov
pseudoviru
carri
wildtyp
protein
ec
valu
respect
although
exhibit
greater
potenc
posit
control
inhibit
fusion
less
activ
wildtyp
merscov
pseudoviru
notabl
display
potenc
similar
fusion
inhibit
result
suggest
unlik
good
correl
blockag
proteinmedi
membran
fusion
inhibit
wildtyp
merscov
infect
one
possibl
explan
discrep
may
lower
target
bind
capabl
inhibit
viru
infect
addit
none
viral
fusion
blocker
display
signific
cytotox
cell
tabl
support
inform
figur
select
index
si
cc
ec
greater
among
clinic
merscov
strain
protein
amino
acid
chang
locat
nhr
domain
posit
select
present
nearli
variant
therefor
next
investig
whether
would
effect
merscov
strain
mutat
strikingli
peptid
effect
inhibit
infect
merscov
pseudovirus
mutat
protein
ec
valu
similar
inhibit
pseudoviru
carri
wildtyp
protein
tabl
support
inform
figur
display
less
potenc
inhibit
infect
pseudovirus
carri
protein
mutat
howev
possess
potenc
similar
merscov
primarili
infect
human
respiratori
tract
test
inhibitori
activ
stapl
peptid
merscov
pseudoviru
infect
human
lungderiv
cell
line
strikingli
could
inhibit
merscov
pseudoviru
infect
cell
ec
valu
respect
agreement
result
observ
experi
use
cell
support
inform
tabl
figur
also
signific
cytotox
cell
concentr
high
support
inform
figur
moreov
evalu
aqueou
solubl
stapl
peptid
aqueou
solubl
mgml
ph
respect
higher
support
inform
tabl
suggest
good
potenti
develop
effect
stapl
helic
propens
next
sought
determin
whether
hydrocarbon
stapl
could
effect
recapitul
nativ
conform
region
merscov
chr
domain
cd
spectroscopi
provid
typic
signatur
maximum
near
nm
doubl
minima
nm
cd
spectra
show
display
random
coil
conform
phosphat
buffer
strikingli
except
insolubl
make
accur
measur
hydrocarbonstapl
peptid
exhibit
structur
helic
among
highli
effect
stapl
peptid
found
greatli
improv
helic
propens
compar
linear
wildtyp
peptid
helic
content
respect
figur
furthermor
stapl
peptid
inde
helic
correpond
uncycl
linear
precursor
support
inform
tabl
data
confirm
success
mimicri
chr
helix
via
cycliz
use
stapl
strategi
interestingli
although
cd
spectra
peptid
similar
differ
inhibitori
potenc
observ
suggest
much
higher
biolog
activ
mere
attribut
helic
propens
henc
follow
targetbind
studi
perform
elucid
mechanisim
action
bind
stapl
peptid
complementari
protein
nhr
domain
previou
studi
shown
articl
peptid
deriv
merscov
protein
chr
domain
bind
nhr
target
form
stabl
hexam
first
sought
determin
interact
stapl
helic
peptid
nativ
nhr
ligand
design
form
stabl
complex
use
cd
spectroscopi
signific
increas
sum
individu
spectra
two
peptid
mix
togeth
equimolar
concentr
indic
interact
led
enhanc
helic
structur
isol
display
random
coil
structur
phosphat
buffer
ph
judg
cd
spectroscopi
consist
previou
report
interact
result
content
complex
respect
cd
signal
mixtur
mixtur
nm
dramat
greater
mathemat
sum
isol
peptid
indic
induct
larg
structur
upon
interact
figur
strikingli
thermal
unfold
transit
valu
reach
respect
figur
togeth
cd
data
consist
fold
form
thermal
stabl
cooper
fold
helic
bundl
stapl
peptid
moder
activ
includ
result
less
stabl
interact
valu
rang
peptid
poor
antivir
activ
show
weak
coiledcoil
interact
support
inform
tabl
result
demonstr
strong
correl
biolog
activ
thermal
stabil
stapl
complex
bind
stapl
peptid
nhrderiv
peptid
confirm
use
nativ
n
page
npage
owe
net
posit
charg
appear
gel
migrat
solvent
nativ
electrophoresi
condit
result
consist
previou
observ
respect
stapl
helic
peptid
variou
antivir
potenc
mix
subject
npage
analysi
shown
figur
form
stabl
complex
evidenc
new
band
upper
posit
gel
concomit
fade
disappear
stapl
peptid
band
suggest
oligomer
complex
form
via
coiledcoil
interact
npage
result
also
indic
stronger
bind
either
bind
base
densiti
residuestapl
peptid
band
observ
articl
gel
figur
support
inform
figur
consist
fusion
assay
cd
spectroscopi
result
inact
peptid
exhibit
nhr
bind
interestingli
mixtur
show
new
band
upper
posit
gel
band
mixtur
much
lower
intens
correspond
band
alon
support
inform
figur
agreement
cd
data
signal
mixtur
dramat
smaller
mathemat
sum
isol
peptid
suggest
addit
distort
conform
due
interact
combin
cd
npage
data
indic
may
associ
viral
nhelic
form
nonhel
complex
aggreg
migrat
gel
thu
result
inhibitori
activ
merscov
infect
size
complex
form
confirm
sediment
veloc
analysi
sva
analyz
sva
sediment
coeffici
complex
complex
correspond
kda
respect
compar
expect
molecular
mass
kda
heterodim
kda
heterodim
conclud
could
associ
form
heterogen
complex
thu
block
merscov
entri
host
cell
figur
support
inform
tabl
pharmacokinet
studi
pharmacokinet
behavior
compar
evalu
rat
rat
g
inject
intraven
three
peptid
mgkg
seven
blood
sampl
collect
sequenti
min
period
three
anim
time
point
concentr
intact
peptid
plasma
determin
lcmsm
analysi
shown
figur
tabl
although
three
peptid
exhibit
similar
vivo
halfliv
mean
valu
maximum
blood
concentr
c
max
greater
meanwhil
observ
dramat
differ
among
area
plasma
curv
extrapol
last
time
point
auc
measur
total
system
exposur
drug
three
compound
auc
compar
consequ
show
lowest
system
clearanc
lh
kg
approxim
less
lh
kg
thu
current
result
indic
develop
potenti
drug
candid
basi
high
potenc
inhibit
infect
diverg
merscov
strain
improv
pharmacokinet
compar
provid
first
exampl
allhydrocarbonstapl
peptid
mimick
nativ
conform
ctermin
short
region
within
merscov
protein
stapl
peptid
abl
block
format
hexamer
coiledcoil
fusion
complex
thu
inhibit
host
cell
membran
fusion
data
show
one
stapl
peptid
preserv
biolog
activ
conform
found
merscov
fusion
machineri
also
good
potenti
develop
antim
therapeut
base
promis
antivir
activ
effect
nativ
ligandbind
capabl
favor
pharmacokinet
format
merscov
fusion
core
chr
nhr
basic
result
interact
wherein
chr
helix
consid
two
distinct
face
ie
buri
hydrophob
surfac
solventexpos
surfac
establish
rule
thumb
underlin
sequenc
structur
coil
coil
reveal
stabil
individu
helic
enhanc
overal
stabil
superhel
protein
structur
motif
therefor
strategi
use
reinforc
secondari
structur
constitu
coil
coil
introduc
intrahel
salt
bridg
solvent
access
site
substitut
noncor
residu
helixfavor
amino
acid
success
appli
hiv
fusion
inhibitor
design
envis
strategi
would
also
applic
optim
lead
compound
found
studi
addit
rather
gener
hydrophob
mutat
buri
residu
futur
design
one
also
consid
place
polar
amino
acid
interact
site
stapl
peptid
could
establish
attract
interhel
electrostat
interact
hydrogen
bond
thu
increas
aqueou
solubl
targetbind
affin
overal
consid
univers
fusion
mechan
employ
class
envelop
virus
studi
establish
paradigm
hydrocarbon
stapl
may
attract
strategi
develop
viral
entri
inhibitor
design
control
viral
epidem
recapitul
certain
peptid
viral
fusion
core
structur
nhrchr
coil
coilmedi
interact
inhibit
gener
peptid
synthesi
peptid
prepar
use
cem
liberti
autom
microwav
peptid
synthes
togeth
fmoc
solidphas
peptid
synthesi
protocol
rinkamid
resin
load
capac
mmolg
briefli
fmoc
protect
group
resin
remov
piperidinedmf
min
natur
amino
acid
coupl
use
n
hexafluorophosph
equiv
dmf
diisopropylethylamin
diea
equiv
nmp
coupl
reagent
equiv
n
protect
amino
acid
equiv
coupl
fmoc
remov
resin
wash
dmf
min
dcm
min
articl
assembl
olefincontain
amino
acid
doubl
coupl
method
perform
achiev
complet
reaction
describ
previous
final
deprotect
peptidebound
resin
treat
acet
acid
vv
min
synthesi
allhydrocarbonstapl
peptid
rcm
reaction
protect
peptid
contain
alanin
r
alanin
perform
onresin
use
firstgener
grubb
catalyst
first
reaction
bottl
contain
peptidebound
resin
kept
lucifug
condit
silver
paper
protect
nitrogen
second
grubb
catalyst
equiv
dichloroethan
ad
resin
mixtur
stir
h
room
temperatur
repeat
treatment
fresh
catalyst
carri
h
obtain
complet
convers
reaction
solut
drain
resin
wash
dmf
min
dcm
min
resin
cleavag
perform
treatment
cleavag
cocktail
contain
tfa
thioanisol
mcresol
water
cleavag
resin
crude
peptid
precipit
use
cold
diethyl
ether
crude
product
purifi
prepar
reversedphas
rp
hplc
puriti
compound
confirm
analyt
rphplc
inform
provid
support
inform
tabl
molecular
weight
peptid
confirm
qfticrm
apex
qe
bruker
germani
inhibit
merscov
sproteinmedi
fusion
assay
merscov
proteinmedi
fusion
assess
describ
previous
brief
cell
express
merscov
protein
enhanc
gfp
egfp
use
effector
cell
cell
express
merscov
receptor
use
target
cell
cell
express
egfp
use
neg
control
cell
cell
plate
plate
per
well
cultur
h
inhibitor
indic
concentr
ad
follow
addit
cell
cell
per
well
cocultur
h
cell
cell
fuse
unfus
cell
count
invert
fluoresc
microscop
nikon
eclips
inhibit
pseudotyp
merscov
infect
merscov
pseudoviru
gener
via
cotransfect
cell
plasmid
well
plasmid
previous
describ
peptid
grade
concentr
mix
pseudoviru
incub
h
room
temperatur
mixtur
ad
cell
fresh
medium
ad
h
later
cell
incub
addit
h
fluoresc
determin
immedi
use
luciferas
kit
promega
ultra
luminomet
tecan
addit
luciferas
substrat
promega
cytotox
assess
cytotox
compound
cell
use
test
pseudotyp
merscov
infect
measur
use
cell
count
kit
dojindo
kumamoto
japan
briefli
test
peptid
grade
concentr
ad
cell
per
well
well
plate
incub
h
addit
incub
h
ad
absorb
nm
measur
h
later
aqueou
solubl
determin
solubl
measur
use
hplcuv
method
stapl
peptid
mg
ad
ml
eppendorf
tube
either
ph
phosphat
buffer
doubledistil
h
ddh
ad
dissolut
shake
h
follow
centrifug
mixtur
rpm
min
satur
supernat
solut
filter
filter
membran
transfer
vial
analysi
hplc
uv
detect
sampl
assay
triplic
quantif
analyt
rphplc
use
zorbax
eclips
column
mm
mm
solvent
tfa
h
solvent
b
tfa
ch
cn
h
flow
rate
mlmin
gradient
solvent
b
solvent
min
aqueou
concentr
determin
comparison
peak
area
satur
solut
standard
curv
plot
peak
area
versu
known
concentr
prepar
solut
test
compound
pb
ddh
mgml
cd
spectroscopi
peptid
dissolv
pb
mm
ph
final
concentr
equimolar
mixtur
test
peptid
incub
min
concentr
cd
spectra
obtain
chirascan
plu
spectropolarimet
appli
photophys
ltd
leatherhead
surrey
uk
measur
paramet
set
follow
wavelength
nm
step
resolut
nm
speed
nmmin
cd
data
shown
mean
residu
ellipt
valu
dmol
taken
correspond
thermal
denatur
monitor
nm
implement
thermal
gradient
npage
stapl
peptid
dissolv
mm
pb
ddh
concentr
respect
stapl
peptid
incub
min
respect
addit
trisglycin
nativ
sampl
buffer
biorad
hercul
ca
sampl
load
onto
trisglycin
gel
trisglycin
sampl
buffer
ph
gel
electrophoresi
carri
constant
voltag
v
room
temperatur
h
gel
stain
coomassi
blue
imag
obtain
champgel
imag
system
sagecr
ltd
beij
china
sva
sva
perform
use
proteomelabtmxlaxli
analyt
ultracentrifug
beckman
coulter
fullerton
ca
equip
threechannel
cell
ti
rotor
sampl
prepar
final
concentr
mm
pb
mixtur
incub
min
initi
scan
rpm
min
data
obtain
rpm
wavelength
nm
h
weightaverag
molecular
weight
calcul
fit
process
sedfit
program
pharmacokinet
assess
rat
weigh
g
obtain
anim
center
beij
institut
pharmacolog
toxicolog
use
pharmacokinet
assess
anim
treat
accord
anim
welfar
act
guid
care
use
laboratori
anim
nih
public
revis
complet
pharmacokinet
experiment
procedur
provid
support
inform
support
inform
avail
free
charg
ac
public
websit
doi
articl
inhibitori
activ
peptid
merscov
infect
cell
solubl
biophys
properti
biolog
activ
uncycl
peptid
biophys
properti
stapl
peptid
summari
sva
result
complex
hplc
method
use
purif
analysi
peptid
compound
stapl
peptid
inhibitor
merscov
infect
pharmacokinet
experi
well
hplc
puriti
character
data
compound
pdf
